Are we repeating mistakes of the past? A review of the evidence for esketamine

This paper summarises the evidence for esketamine nasal spray for treatment resistant depression. It suggests that trials may not have been fully conclusive for efficacy, and that significant adverse reactions (e.g. bladder damage) may be been overlooked in the regulatory review.


British Journal of Psychiatry